Cycle Pharmaceuticals (Cycle Pharma) has entered into an exclusive U.S. commercialization agreement with Handa Therapeutics, ...

Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...

Cycle Pharmaceuticals (Cycle Pharma) has entered into an exclusive U.S. commercialization agreement with Handa Therapeutics, LLC (Handa), for PHYRAGO, an FDA approved drug for treating two types of le ...

"I thought I might be dead in a few months" - Kareem Abdul-Jabbar on getting diagnosed with leukemia originally appeared on ...

Italy’s Robin Foà, MD, an iconic European clinician-researcher, has been at forefront of hematology’s transformation for half ...

Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.

Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of ...

"Imcranib 100", the first targeted cancer drug in tablet form developed and produced in Thailand, is the result of the research and development work of Her Royal Highness Princess Chulabhorn ...

DelveInsight's, “Gastrointestinal Stromal Tumors Pipeline Insight 2025” report provides comprehensive insights about 25+ ...

Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...

Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant ...